Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in moderate-to-severe patients was based on pivotal study results ...
Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...
We’re pleased to announce a new collaboration between SPM Dean's Executive Council member Ravi Sawhney 's new venture PA-AI ...
On March 11, we held our Spring Fireside Chat with Kevin McDonnell, Chief Financial Officer (CFO) of AeroVironment. Students ...
Thousands of skilled professionals are mobilised by the North Korean state involving distinct roles for recruiters, facilitators, IT workers & brokers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results